Earn Pharmacology CE Credit in an Easy way!

What Makes Our CE "Simply the Best!"

    • Features concise up-to-date lectures with full slideshows
    • PowerPoint slide handouts for FREE download
    • Available 24/7 to use at your leisure
    • Fast forward/rewind capability so you can be sure to master the material

    • Full screen capability; perfect for tablet users
    • Portable: Carry with you on your smartphone or laptop
    • Access on your computer immediately!
    • One month to complete from time of purchase.
    • Obtain needed CE and pharmacology contact hours

Barkley & Associates, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 080518.

Provider approved by the California Board of Registered Nursing, Provider Number CEP 15436, for the specified number of contact hours.

All NP state regulatory agencies (i.e., State Boards of Nursing) and national certifying bodies (e.g., ANCC, AANP, AACN, PNCB, and NCC)
recognize and accept AANP CE credit for recertification! 

Advanced Pharmacology is an ever-changing field. Standard safety precautions must be followed, but as new research and clinical experience broaden our knowledge, changes in treatment and drug therapy may become necessary or appropriate. Readers are advised to check the most current product information provided by the manufacturer of each drug to be administered to verify the recommended dose, the method and duration of administration and contraindications. It is the responsibility of the licensed prescriber, relying on expertise and knowledge of the patient, to determine dosages and the best treatment for each individual patient. Neither Barkley & Associates nor any contributing authors assume any responsibility for any injury and/or damage to persons or property arising from this publication.


In this session, the nurse practitioner will learn about new drugs recently introduced to the market for a variety of indications including pain, infection, hypertension, endocrine diseases, and others. Tips for how to best monitor the market for drug updates are included in this content. Additionally, drugs on the FDA watch list, or those recently removed from the market are discussed. Drugs which were recently issued black box warnings and how this process occurs is also highlighted.

Included in this talk is information on:

  • Populations susceptible to drug errors and how to minimize these errors in practice; pediatric and elderly populations are particularly covered

  • Joint Commission updates and recommendations on safety and monitoring of drugs

  • Latest pharmacologic updates in pediatric and adult medicine pertaining to safe drug use

Clinical Aspects of Drugs of Abuse Across the Lifespan

The profile of drug abuse in the United States is ever-changing.  In this presentation, the participant will learn about the latest trends in drugs of abuse including illicit drugs, alcohol, prescription drugs and designer drugs.  Both stimulant and sedative drugs are addressed with respect to effects on the body, outcomes of long-and short-term abuse, geographic trends, and differences across the lifespan.  Interventions, treatment and management of the patient who abuses drugs are discussed per agent.  Drug testing and detection methods are examined, along with common methods for adulterating drugs tests.


Included in this talk is information on:

  • Trends, symptomatology and treatment of stimulant drugs of abuse including cocaine and crack, methamphetamine, bath salts and Ecstasy
  • Trends, symptomatology and management of depressant drugs of abuse including marijuana, Spice, GHB, alcohol and inhalants
  • The problem of prescription drug abuse, including trends, most problematic drugs, management of patients who become addicted to these agents
  • Basics of drug testing including knowledge of persistence of drugs in the system, the immunoassay, GC-MS, and checking for adulterants of a drug test